Pergolide in Parkinson's disease: time for a change?

Lancet. 2004 Jun 5;363(9424):1907-8. doi: 10.1016/S0140-6736(04)16369-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Heart Valve Diseases / chemically induced*
  • Humans
  • Parkinson Disease / drug therapy*
  • Pergolide / adverse effects*
  • Pergolide / therapeutic use

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Pergolide